Morningside Ventures Launches Adiso Therapeutics to Advance Novel Therapies for Inflammatory Diseases Adiso Emerges from Stealth with a Pipeline of Small Molecules and Live Biotherapeutic Products, Including Three Clinical-Stage Programs Targeting Ulcerative Colitis and C. difficile  Scott Megaffin Appointed Chief Executive Officer   NEWS PROVIDED BY Adiso Therapeutics  [...]